As EGFR mutations were observed exclusively in adenocarcinoma patients, we investigated the relationship between the clinical features and other genetic alterations in these adenocarcinoma patients (n=108) and their mutations (Table 4). This evidence concerns the gene EGFR and adenocarcinoma.